Mettler-Toledo International (MTD) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Mettler-Toledo International (NYSE:MTD) from a hold rating to a buy rating in a research report released on Wednesday. They currently have $640.00 price target on the medical instruments supplier’s stock.

According to Zacks, “Mettler-Toledo is benefiting from strong product pipeline. The acquisition of Biotix is helping the company gain access to indirect distribution channels with robust secondary brands. We remain positive about Mettler-Toledo’s leading market position, focus on product development and cost reduction, sales and marketing efforts and operational excellence programs. The company is expected to benefit from strong growth prospects in product inspection and services. Estimates have been stable lately ahead of the company’s Q4 earnings release. The company has a positive record of earnings surprises in recent quarters. However, seasonality, volatility in emerging market growth, foreign exchange risk and business concentration in China remain overhangs. In past one year, the stock has slightly underperformed the industry it belongs.”

How to Become a New Pot Stock Millionaire

A number of other equities analysts have also weighed in on the stock. Morgan Stanley decreased their price objective on shares of Mettler-Toledo International from $595.00 to $568.00 and set an equal weight rating for the company in a report on Wednesday. Goldman Sachs lowered shares of Mettler-Toledo International from a buy rating to a neutral rating in a report on Monday, April 9th. Deutsche Bank boosted their price objective on shares of Mettler-Toledo International from $600.00 to $630.00 and gave the stock a hold rating in a report on Thursday, March 1st. Robert W. Baird decreased their price objective on shares of Mettler-Toledo International from $675.00 to $630.00 and set a neutral rating for the company in a report on Friday, February 9th. Finally, Citigroup upgraded shares of Mettler-Toledo International from a neutral rating to a buy rating and boosted their target price for the company from $685.00 to $692.00 in a research note on Friday, February 9th. Seven research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The stock presently has an average rating of Hold and a consensus price target of $641.00.

Shares of NYSE MTD opened at $568.21 on Wednesday. Mettler-Toledo International has a twelve month low of $473.55 and a twelve month high of $697.26. The company has a market capitalization of $14,513.41, a P/E ratio of 32.34, a PEG ratio of 2.23 and a beta of 1.20. The company has a quick ratio of 1.09, a current ratio of 1.46 and a debt-to-equity ratio of 1.75.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, February 8th. The medical instruments supplier reported $5.97 earnings per share for the quarter, topping analysts’ consensus estimates of $5.93 by $0.04. Mettler-Toledo International had a net margin of 13.80% and a return on equity of 94.54%. The company had revenue of $778.03 million during the quarter, compared to analyst estimates of $764.26 million. During the same period in the previous year, the business earned $5.28 EPS. The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. sell-side analysts expect that Mettler-Toledo International will post 20.24 earnings per share for the current fiscal year.

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the business’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $605.20, for a total transaction of $181,560.00. Following the completion of the sale, the chief financial officer now directly owns 5,599 shares in the company, valued at approximately $3,388,514.80. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, insider Waldemar Rauch sold 4,500 shares of the business’s stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $614.18, for a total transaction of $2,763,810.00. Following the sale, the insider now owns 8,068 shares of the company’s stock, valued at $4,955,204.24. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 28,268 shares of company stock valued at $17,497,059. Company insiders own 4.80% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Coastline Trust Co raised its stake in Mettler-Toledo International by 16.2% during the 3rd quarter. Coastline Trust Co now owns 575 shares of the medical instruments supplier’s stock valued at $360,000 after buying an additional 80 shares during the last quarter. Conning Inc. grew its position in shares of Mettler-Toledo International by 25.7% during the 4th quarter. Conning Inc. now owns 440 shares of the medical instruments supplier’s stock valued at $273,000 after acquiring an additional 90 shares during the period. Caisse DE Depot ET Placement DU Quebec grew its position in shares of Mettler-Toledo International by 2.9% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 3,600 shares of the medical instruments supplier’s stock valued at $2,264,000 after acquiring an additional 100 shares during the period. New Mexico Educational Retirement Board grew its position in shares of Mettler-Toledo International by 4.2% during the 4th quarter. New Mexico Educational Retirement Board now owns 2,500 shares of the medical instruments supplier’s stock valued at $1,549,000 after acquiring an additional 100 shares during the period. Finally, Advisor Group Inc. grew its position in shares of Mettler-Toledo International by 6.9% during the 4th quarter. Advisor Group Inc. now owns 1,770 shares of the medical instruments supplier’s stock valued at $1,097,000 after acquiring an additional 115 shares during the period. Institutional investors and hedge funds own 92.45% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece was originally reported by Week Herald and is the property of of Week Herald. If you are reading this piece on another publication, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The correct version of this piece can be viewed at https://weekherald.com/2018/04/15/mettler-toledo-international-mtd-upgraded-at-zacks-investment-research.html.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.

Get a free copy of the Zacks research report on Mettler-Toledo International (MTD)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply